China Universal Asset Management Company’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.34M Sell
22,981
-2,559
-10% -$139K 0.08% 180
2026
Q1
$1.48M Buy
25,540
+4,209
+20% +$229K 0.11% 140
2025
Q4
$984K Sell
21,331
-1,425
-6% -$63.7K 0.08% 190
2025
Q3
$820K Sell
22,756
-9,154
-29% -$303K 0.07% 194
2025
Q2
$1.04M Buy
31,910
+6,083
+24% +$199K 0.1% 161
2025
Q1
$975K Sell
25,827
-601
-2% -$48.1K 0.09% 189
2024
Q4
$2.16M Buy
26,428
+4,962
+23% +$493K 0.2% 104
2024
Q3
$2.45M Buy
21,466
+8,685
+68% +$783K 0.27% 77
2024
Q2
$965K Sell
12,781
-8,059
-39% -$549K 0.14% 104
2024
Q1
$1.42M Sell
20,840
-21,327
-51% -$1.48M 0.18% 101
2023
Q4
$2.65M Sell
42,167
-243
-0.6% -$12.6K 0.52% 57
2023
Q3
$2.16M Buy
42,410
+1,182
+3% +$58.3K 0.63% 49
2023
Q2
$2.06M Buy
41,228
+40,144
+3,703% +$1.9M 0.64% 47
2023
Q1
$40.6K Buy
1,084
+281
+35% +$11.9K 0.01% 166
2022
Q4
$38.5K Buy
803
+248
+45% +$9.73K 0.02% 144
2022
Q3
$13K Buy
+555
New +$14.1K 0.01% 183

Other funds holding PCVX

China Universal Asset Management Company's PCVX Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Vaxcyte (PCVX) stake by 10% in Q2 2026, selling an estimated $139K and leaving 22,981 shares worth $1.34M. The position accounts for 0.08% of the portfolio, ranked #180.

China Universal Asset Management Company first reported a position in PCVX in Q3 2022 and has held it in 16 quarters since. The position peaked at $2.65M in Q4 2023. 37 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • China Universal Asset Management Company held 22,981 shares of Vaxcyte worth $1.34M as of Q2 2026.
  • China Universal Asset Management Company sold 2,559 Vaxcyte shares in Q2 2026, an estimated $139K.
  • Vaxcyte made up 0.08% of China Universal Asset Management Company's portfolio in Q2 2026, its #180 holding.
  • China Universal Asset Management Company first reported a position in Vaxcyte in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's Vaxcyte position peaked at $2.65M in Q4 2023.
  • 37 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.